Representative before the EPO

Employment test 51 - 200 employees
Company dna d young and co llp
operating since 1891
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 3 EP applications Stephanie Wroe has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 21, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12705199

RECOMBINANT FELINE LEUKEMIA VIRUS VACCINE CONTAINING OPTIMIZED FELINE LEUKEMIA VIRUS ENVELOPE GENE

IPC classification:
A61K 39/12, C07K 14/005, C12N 15/86
Applicant:
Centre National de la Recherche Scientifique (CNRS)
Applicant:
Institut Gustave Roussy
Applicant:
Université Paris Sud (UPS) Paris XI
Applicant:
Merial Limited
Agent:
Multiple attorneys, D Young & Co LLP
Status:
EXAMINATION REQUESTED
EP12726998

VACUUM -ASSISTED PRESERVATION OF BIOLOGICAL PRODUCTS, IN PARTICULAR OF VACCINES

IPC classification:
A61K 9/19, F26B 5/06
Applicant:
Merial Limited
Applicant:
Merial, Inc.
Agent:
Multiple attorneys, D Young & Co LLP
Status:
PATENT GRANTED
EP11839515

COMPOSITIONS AND METHODS FOR TREATING ANDROGEN RECEPTOR DEPENDENT DISORDERS INCLUDING CANCERS

IPC classification:
A61K 31/415, C12N 15/11, C12N 15/113
Applicant:
Roche Innovation Center Copenhagen A/S
Agent:
Stephanie Wroe, D Young & Co LLP
Status:
EXAMINATION IN PROGRESS

Please Sign in to use this feature